Stocklytics Platform
Asset logo for symbol HRTX
Heron Therapeutics
HRTX69
$1.84arrow_drop_down1.60%-$0.03
Penny Stock
Asset logo for symbol HRTX
HRTX69

$1.84

arrow_drop_down1.60%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Heron Therapeutics (HRTX) Stocklytics Forecast

Heron Therapeutics Inc (HRTX) is a pharmaceutical company that focuses on developing innovative treatments for patients with pain and other conditions. The company's stock price has been subject to speculation and predictions by analysts and investors. While it is impossible to accurately predict the future stock price of HRTX, there are some factors that can provide insights into its potential performance.
Firstly, the company has a strong pipeline of drugs in development, which could drive future growth and revenue. One of its key products is HTX-011, a potential non-opioid pain reliever that has shown promising results in clinical trials. If approved by regulatory authorities, HTX-011 could become a significant contributor to the company's revenue stream.
add Heron Therapeutics to watchlist

Keep an eye on Heron Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Heron Therapeutics (HRTX) stock?

Analysts have set a target price of $12 for Heron Therapeutics (HRTX), based on forecasts from 17 analysts. The predicted price range extends from a high of $50 to a low of $4. This represents a potential increase of up to 2.61K% and a decrease of 116.8% from the current price of $1.84. These forecasts are as of 2017 Sep 27.
help

What are the analyst ratings for Heron Therapeutics (HRTX) stock?

The analyst ratings for Heron Therapeutics (HRTX) are distributed as follows: 4 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Heron Therapeutics .
help

What is the AI price prediction for Heron Therapeutics (HRTX) stock?

At present, there is no AI or machine-learning-based price prediction available for Heron Therapeutics (HRTX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level